title: Antilymphocyte-antibody prophylaxis: review of the adult experience in heart transplantation.
authors.affiliation: University of Utah Health Sciences Center, Veterans Affairs Medical Center, Salt Lake City, USA.
authors.forename: D O
authors.initials: DO
authors.lastname: Taylor
authors.forename: A G
authors.initials: AG
authors.lastname: Kfoury
authors.forename: B
authors.initials: B
authors.lastname: Pisani
authors.forename: E H
authors.initials: EH
authors.lastname: Hammond
authors.forename: D G
authors.initials: DG
authors.lastname: Renlund
mesh_terms: D000328:Adult; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology* / Q000401:mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000453:epidemiology; D015996:Survival Rate
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3